Year III: Development of M. mercenaria Neoplastic Hemocytes as a Novel Alternative Experimental Model for BCL-2 Interactions in Blood Cancers: An Application for Targeted Drug Studies
ISEF · 2026 Animal Sciences
Overview
Anti-apoptotic B-cell leukemia/lymphoma (Bcl-2) proteins are overexpressed in around half of human cancers, linked to tumorigenesis, chemotherapy resistance, and poor prognosis. Effectively modeling this complex molecular interaction is essential for its progression as a therapeutic target, yet the costliness and time-intensive nature of current models limit study. However, disseminated neoplasia (DN), a transmissible cancer naturally occurring in the hemocyte "blood" cells of bivalve mollusks, shares notable similarities to human leukemia. To develop M. mercenaria as an effective model, this study examined neoplasia transmission between bivalves. Cohabitation yielded increased tumor cell fraction in healthy clams after 3 months. Exposure to hypoxic conditions promoted DN progression after 7 days, and cancer cell inoculation elevated transmission in healthy clams (p=0.0409). Excess lipid accumulation in tissue was characterized as a new potential DN biomarker, aiding in future disease identification. M. mercenaria were evaluated for functional similarities between human and bivalve Bcl-2 after exposure to inhibitors at varying concentrations. Significant changes (p=0.0209) in relative protein expression were observed in SDS-PAGE, suggesting Bcl-2 inhibitors downregulate Bcl-2 expression in M. mercenaria. Clams treated with concentrations >0.3 mg/kg maintained suppressed tumor progression in the months following exposure. Results show promise for M. mercenaria as naturally occurring in vivo cancer models for Bcl-2 interactions, with analogous biomarkers and physiological responses identified. Applications include high-throughput drug screening, minimizing vertebrate testing, and reducing cost per specimen >50-fold for early novel drug candidate screening.
Awards (1)
- Third Award of $1,200 $1,200
Competition history
- ISEF 2026
Resources
Related projects
ISEF · 2025
Year II: Assessing Marine Bivalves as Novel Invertebrate Models for Targeting Anti-apoptotic BCL-2 Family Proteins in Blood Cancer: The in vivo Effects of Ursolic Acid and Gossypol Acetic Acid on Tumor Cells in Mercenaria mercenaria
ISEF · 2018
Wasp Venom Stings Cancer: Investigation of Dictyostelium as a Model Organism and the Potential of an Improved Treatment Delivery System
ISEF · 2017
Controlling Noxa Protein Expression by a Novel Approach to Study Its Function in Leukemic Cells, Phase II
ISEF · 2025
A Novel Biological Treatment for Antibiotic-Resistant Vibrio Infections in Aquaculture
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair